LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: The global market for molecular transplant diagnostics is projected to grow at an average annual rate of 9% up to 2021 (Photo courtesy of Kalorama Information).

Global Molecular Transplant Diagnostics Market to Triple Revenue

The global market for molecular transplant diagnostics is estimated to be over USD 300 million and is projected to grow at an average annual rate of 9% up to 2021. These are the latest findings of Kalorama Information, an independent medical market research firm. More...
09 May 2017
Image: The Calbiotech team (Photo courtesy of Calbiotech Group).

Transasia Bio-Medicals Acquires Calbiotech Group

Transasia Bio-Medicals Ltd., an in-vitro diagnostic company, has acquired immunoassay developer and manufacturer Calbiotech Group of Companies through its subsidiary Erba Mannheim. More...
01 May 2017

Global Volume of IVD Procedures Exceeds 21 Billion in 2016

The global volume of in vitro diagnostic (IVD) procedures, excluding the over-the counter (OTC) point of care (POC) market and professional POC glucose monitoring activity, reached 21.4 billion in 2016. Currently, an estimated 80% of all conditions diagnosed by physicians worldwide are based at least partially on the results of IVD procedures. More...
18 Apr 2017
Image: The global market for clinical chemistry analyzers is expected to reach USD 16.0 billion by 2025 (Photo courtesy of Medgadget).

Global Analyzer Market to Reach USD 16.0 Billion by 2025

The global market for clinical chemistry analyzers is expected to reach USD 16.0 billion by 2025, driven by their increased adoption due to the growing prevalence of chronic diseases, fueled further by an increasing geriatric and bariatric population, which is highly susceptible to chronic diseases. The resulting high sample volume requiring high capability analyzing devices will drive the growth of the global clinical chemistry analyzers market, going forward. More...
31 Mar 2017

Streck Enters Distribution Agreement with Dow Biomedica

Streck, Inc., which develops and manufactures products for clinical and research laboratories, has entered into a distribution agreement for its cell stabilization, molecular and flow cytometry products with Dow Biomedica, a distributor of diagnostic products specializing in immunology, microbiology and QC materials. More...
31 Mar 2017

Greiner Bio-One to Serve Spain and Portugal through Distribution Subsidiaries

Greiner Bio-One has acquired its long-standing distribution partners, VacuetteEspaña and Vacuette Portugal, which will now allow the medical technology company to serve its customers in Spain and Portugal directly through its own distribution subsidiaries. More...
28 Mar 2017

POCT Market Reaches USD 18 Billion in 2016

Sales of point of care (POC) diagnostic testing, both professional testing and self-testing, reached USD 18.4 billion in 2016, driven by emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices that aim to provide expedited diagnosis where the patient is seen or in the patient’s home. These new technologies are allowing POC devices to generate quantitative lab-quality test results and transfer them automatically to an information system, a remote caregiver service for consultation or an electronic medical record. More...
10 Mar 2017
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hematology Consumables
Bioblood Devices
New
Clinical Informatics Platform
CLARION™


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
INTEGRA BIOSCIENCES AG